NASDAQ:CMPX | Profit Breakdown | Compass Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$26.98M-$25.15M
2026-03-31-$20.3M-$18.32M
2025-12-31$0.00-$17.99M-$15.72M
2025-09-30$0.00-$15.82M-$14.26M
2025-06-30$0.00-$21.07M-$19.88M
2025-03-31-$17.97M-$16.63M-$16.63M
2024-12-31$0.00-$16.57M-$15.03M
2024-09-30$0.00-$12.24M-$10.48M
2024-06-30$850,000.00-$15.05M-$13.08M-$13.08M
2024-03-31-$12.77M-$10.79M-$10.79M
2023-12-31$0.00-$15.39M-$13.42M-$13.42M
2023-09-30$0.00-$11.93M-$9.96M-$9.96M
2023-06-30$0.00-$13.34M-$11.28M-$11.28M
2023-03-31-$9.71M-$7.84M-$7.84M
2022-12-31-$12.89M-$11.59M-$11.59M
2022-09-30-$12.6M-$11.98M-$11.98M
2022-06-30-$8.99M-$8.49M-$8.49M
2022-03-31-$7.18M-$7.16M-$7.16M
2021-12-31-$13M-$12.99M-$12.98M
2021-09-30-$5.85M-$5.98M-$5.98M
2021-06-30-$55.69M-$55.79M-$55.8M
2021-03-31-$7.34M-$7.42M-$7.42M
2020-12-31-$7.95M-$8.39M-$8.39M
2020-09-30-$8.96M-$9.15M-$9.15M
2020-06-30-$5.07M-$5.54M-$5.56M
2020-03-31-$5.83M-$6.39M-$6.4M
2019-12-31-$6.4M-$6.6M-$6.61M
2019-09-30-$8.38M-$8.53M-$8.55M
2019-06-30-$8.67M-$8.78M-$8.81M
2019-03-31-$7,813.00-$10.77M
2018-12-31-$9,267.00-$10,142.00
2018-09-30-$7,785.00-$8,556.00
2018-06-30-$7,894.00-$8,474.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$0.00-$72.84M-$66.49M
2024-12-31$850,000.00-$56.63M-$49.38M
2023-12-31$0.00-$50.36M-$42.49M-$42.49M
2022-12-31-$41.66M-$39.23M-$39.23M
2021-12-31-$81.88M-$82.18M-$82.18M
2020-12-31-$27.81M-$29.47M-$29.5M
2020-03-31-$32,105.00-$37,483.00
2019-12-31-$34.05M-$34.65M-$34.74M
2019-03-31-$32,759.00-$36,037.00